(Q3)Mar 31, 2021 | (Q2)Dec 31, 2020 | (Q1)Sep 30, 2020 | (FY)Jun 30, 2020 | (Q4)Jun 30, 2020 | (Q3)Mar 31, 2020 | (Q2)Dec 31, 2019 | (Q1)Sep 30, 2019 | (FY)Jun 30, 2019 | (Q4)Jun 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -11,028.02%-28.6K | -30.01K | -553.10%-47.16K | 185.54%101.02K | 412.71%108.49K | 99.44%-257 | 0 | 78.61%-7.22K | 75.19%-118.09K | 92.62%-34.7K |
Net income from continuing operations | -288.49%-50.98K | -43.04%-218.01K | 16.81%-77.55K | 74.35%-139.72K | 131.43%78.87K | 172.48%27.05K | -61.16%-152.41K | 42.38%-93.22K | 42.89%-544.64K | 50.09%-250.96K |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -5,078.70%-5.59K | --0 |
Asset impairment expenditure | ---- | ---- | ---- | --1.35M | ---- | ---- | ---- | ---- | --0 | ---- |
Unrealized gains and losses of investment securities | --0 | --100.38K | --34.61K | --79.43K | --79.43K | --0 | --0 | --0 | --0 | ---- |
Remuneration paid in stock | ---- | ---- | ---- | --11.82K | ---- | ---- | ---- | ---- | --0 | ---- |
Other non cashItems | 110.77%11.2K | -68.59%9.3K | -93.60%1.89K | -908.69%-1.18M | -1,440.68%-1.14M | -615.47%-103.99K | 43.61%29.61K | 43.62%29.61K | 919.06%146.36K | --84.94K |
Change In working capital | -85.41%11.19K | -36.22%78.32K | -110.84%-6.12K | -106.47%-18.48K | -308.91%-274.35K | 368.22%76.68K | 68.13%122.8K | -48.74%56.39K | -38.33%285.78K | 600.21%131.32K |
-Change in prepaid assets | --0 | --4.25K | --6.39K | ---12.76K | ---- | ---- | --0 | --0 | --0 | ---- |
-Change in payables and accrued expense | -85.41%11.19K | -39.69%74.07K | -122.18%-12.5K | -102.00%-5.72K | -299.19%-261.58K | 368.22%76.68K | 68.13%122.8K | -48.74%56.39K | -25.95%285.78K | 600.21%131.32K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -11,028.02%-28.6K | ---30.01K | -553.10%-47.16K | 185.54%101.02K | 412.71%108.49K | 99.44%-257 | --0 | 78.61%-7.22K | 75.19%-118.09K | 92.62%-34.7K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 8.26%-41.28K | 99.98%-6 | ||||||||
Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 8.26%-41.28K | 99.98%-6 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 8.26%-41.28K | 99.98%-6 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -82.96%100.01K | 0 | ||||||||
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 296.01%100.01K | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -82.96%100.01K | --0 |
Net cash flow | ||||||||||
Beginning cash position | 9,871.54%38.19K | 16,648.04%64.15K | 1,285.19%108.88K | -88.31%7.86K | -99.70%126 | 525.56%383 | -89.55%383 | -88.31%7.86K | 346.52%67.22K | 1,769.99%42.56K |
Current changes in cash | -11,028.02%-28.6K | ---30.01K | -553.10%-47.16K | 270.17%101.02K | 412.65%108.49K | -100.65%-257 | --0 | 88.04%-7.22K | -190.21%-59.36K | -144.39%-34.7K |
Effect of exchange rate changes | --0 | --4.06K | 1,048.83%2.43K | ---- | ---- | --0 | --0 | 91.91%-256 | ---- | ---- |
End cash Position | 7,512.70%9.59K | 9,871.54%38.19K | 16,648.04%64.15K | 1,285.19%108.88K | 1,285.19%108.88K | -99.70%126 | 525.56%383 | -89.55%383 | -88.31%7.86K | -88.31%7.86K |
Free cash from | -11,028.02%-28.6K | ---30.01K | -553.10%-47.16K | 163.39%101.02K | 412.65%108.49K | 99.58%-257 | --0 | 88.04%-7.22K | 69.41%-159.37K | 93.18%-34.7K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data